Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection

European Journal of Pediatrics

Volumn 173, Issue 4, 2014, Pages 533-536

  Okamoto, Takayuki ^a   Sato, Yasuyuki ^a   Yamazaki, Takeshi ^a   Hayashi, Asako ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacteria; Febrile urinary tract infection; MERS; Pyelonephritis; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; PREDNISOLONE; SUCCIMER TC 99M; TACROLIMUS; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ARTICLE; BACKACHE; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; CORPUS CALLOSUM; DISEASE ASSOCIATION; ENCEPHALITIS; FEMALE; FEVER; HEADACHE; HUMAN; KIDNEY SCINTISCANNING; MILD ENCEPHALITIS ENCEPHALOPATHY WITH A REVERSIBLE SPLENIAL LESION; NAUSEA AND VOMITING; NEPHROTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYELONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY TRACT INFECTION; VESICOURETERAL REFLUX; DIAGNOSTIC USE; ENCEPHALOMYELITIS; ISOLATION AND PURIFICATION; KIDNEY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; SCINTISCANNING; URINARY TRACT INFECTIONS;

ADOLESCENT; ENCEPHALOMYELITIS; FEMALE; FEVER; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MAGNETIC RESONANCE IMAGING; PREDNISOLONE; PYELONEPHRITIS; RADIOPHARMACEUTICALS; TACROLIMUS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; URINARY TRACT INFECTIONS;

EID: 84897026428     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-013-2199-9     Document Type: Article

References (14)

1. Bulakbasi N, Kocaoglu M, Tayfun C, Ucoz T (2006) Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 27(9):1983-1986 (Pubitemid 44556521)
2. Choi J, Kim ST, Craft J (2012) The pathogenesis of systemic lupus erythematosus - an update. Curr Opin Immunol 24(6):651-657. doi:10.1016/j.coi. 2012.10.004
3. Ganapathy S, Ey EH, Wolfson BJ, Khan N (2008) Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis. Pediatr Radiol 38(11):1243-1245
4. Gurgoze MK, Akarsu S, Yilmaz E, Godekmerdan A, Akca Z, Ciftci I, Aygun AD (2005) Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 20(10):1445-1448. doi:10.1007/s00467-005-1941-6 (Pubitemid 41403421)
5. Hoshino A, Saitoh M, Oka A, Okumura A, Kubota M, Saito Y, Takanashi J, Hirose S, Yamagata T, Yamanouchi H, Mizuguchi M (2012) Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 34(5):337-343. doi:10.1016/j.braindev.2011.07.012
6. Miyata R, Tanuma N, Hayashi M, Imamura T, Takanashi J, Nagata R, Okumura A, Kashii H, Tomita S, Kumada S, Kubota M (2012) Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). Brain Dev 34(2):124-127. doi:10.1016/j.braindev.2011.04.004
7. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection (1999). Pediatrics 103 (4 Pt 1):843-852
8. Prilipko O, Delavelle J, Lazeyras F, Seeck M (2005) Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia 46(10):1633-1636. doi:10.1111/j.1528-1167.2005.00256.x (Pubitemid 44921938)
9. Sheu JN, Chen MC, Lue KH, Cheng SL, Lee IC, Chen SM, Tsay GJ (2006) Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine 36(5-6):276-282. doi:10.1016/j.cyto.2007.02.006
10. Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, Suzuki M, Yamamoto T, Shimono T, Ichiyama T, Taoka T, Sohma O, Yoshikawa H, Kohno Y (2004) Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 63(10):1854-1858 (Pubitemid 39532380)
11. Takanashi J (2009) Two newly proposed infectious encephalitis/ encephalopathy syndromes. Brain Dev 31(7):521-528. doi:10.1016/j.braindev.2009. 02.012
12. Takanashi J, Maeda M, Hayashi M (2005) Neonate showing reversible splenial lesion. Arch Neurol 62(9):1481-1482. doi:10.1001/archneur.62.9.1481, author reply 1482
13. Takanashi J, Shirai K, Sugawara Y, Okamoto Y, Obonai T, Terada H (2012) Kawasaki disease complicated bymild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci 315(1-2):167-169. doi:10.1016/j.jns.2011.11.022
14. Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF (2010) Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 62(7):2064-2072. doi:10.1002/art.27442